Diagnostic value of ROCK2 protein in immune checkpoint inhibitors-associated myocarditis

Caie Li1, Yucheng Jin2, Jie Ma1

  • 1Department of Cardiology, The Second Hospital of Lanzhou University, Lanzhou 730030, China.

Abstract

Insights

Rho-associated kinase 2 (ROCK2) protein is elevated in patients with immune checkpoint inhibitor (ICI)-associated myocarditis. ROCK2 detection may improve diagnosis of this cardiovascular side effect.

Area of Science:

  • Cardiovascular research
  • Oncology
  • Immunology

Background:

  • Immune checkpoint inhibitors (ICIs) improve cancer treatment but can cause myocarditis.
  • Diagnosing ICI-associated myocarditis is difficult due to non-specific biomarkers.
  • Rho-associated kinase 2 (ROCK2) may contribute to myocarditis pathogenesis.

Purpose of the Study:

  • To assess ROCK2 protein levels in ICI-associated myocarditis.
  • To evaluate ROCK2 as a diagnostic marker for ICI-associated myocarditis.
  • To provide insights for improved myocarditis management.

Main Methods:

  • Compared ROCK2 levels in 10 ICI-treated patients with myocarditis versus 10 without.
  • Measured ROCK2 and inflammatory markers using ELISA.
  • Utilized cardiac imaging, ECG, and echocardiography for clinical assessment.

Main Results:

  • ROCK2 expression was significantly higher in myocarditis patients (p < 0.001).
  • Elevated inflammatory markers (hs-CRP, IL-1β, IL-17) and cardiac markers (NT-proBNP, sST2) were observed.
  • ROCK2 and inflammatory markers decreased after treatment cessation and glucocorticoid use.

Conclusions:

  • Elevated ROCK2 protein is a potential biomarker for ICI-associated myocarditis.
  • Combining ROCK2 with traditional markers may enhance diagnostic accuracy.
  • Further research into ROCK2 inhibition for myocarditis treatment is warranted.